Divis Laboratories Ltd's Q4FY18 standalone net profit rises 0.89% yoy to Rs261.60cr : Misses Estimates

The company’s standalone revenue stood at Rs1,087.95cr, up 1.99% yoy and 4.82% qoq.

May 29, 2018 06:05 IST India Infoline Research Team

Divis Laboratories Ltd Q4FY18

Standalone Results Q4FY18: (Rs. in cr)

Q4FY18 YoY (%)
Revenue 1,087.95 2.0
EBITDA 386.50 6.8
EBITDA Margin (%) 35.5 159
Net Profit (adjusted) 261.60 0.9
***EBITDA margin change is bps
View

Accumulate

Reco. Price

1177

Last updated on

14-May-2018



Divis Laboratories’ revenue in Q4FY18 grew by 2% yoy to Rs1,088cr. EBITDA grew by 6.8% yoy to Rs386.5cr in Q4FY18. EBITDA margins were at 35.5% in Q4FY18 vs. 31.4% in Q3FY18 vs. 33.9% in Q4FY17.  PAT grew by 0.9% yoy to Rs261.6cr in Q4FY18.
  • The decline in the material cost was offset by higher employee cost.
  • Material cost declined 3.2% yoy to Rs407.6cr. As % of sales, material cost stood at 37.5% in Q4FY18 vs. 39.5% in Q4FY17.
  • Employee cost increased by 25.8% to Rs125.8cr. As % of sales, employee cost stood at 11.6% in Q4FY18 vs. 9.4% in Q4FY17.
  • Other expenses as % of sales stood at 15.4% in Q4FY18 vs. 17.2% in Q4FY17.
  • The company's Unit-1 at Choutuppal, Telangana State has cleared the general cGMP USFDA inspection in May 2018 without any observations.
  • The board has recommended a dividend of Rs 10/share.

Technical View:

Divis Laboratories Ltd is currently trading at Rs. 1,073.70, down by 18.3 points or 1.68% from its previous closing of Rs. 1,092 on the BSE.
The scrip opened at Rs. 1,095 and has touched a high and low of Rs. 1,095 and Rs. 1,060.10 respectively. So far 4,07,780 (NSE+BSE) shares were traded on the counter. The stock is currently trading above its 50 DMA.

Related Story